|

楼主 |
发表于 2025-2-6 15:36:45
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-2-6 16:03 编辑 7 p+ z" l" ?0 [0 V
! @7 j/ h2 _ L! ]' o. t
今年的ISC大会Late-Breaking Science(重磅研究)已经出炉,国内单位入选情况
3 ~9 R& Z% }6 I% P& R2 V7 D: t
3 k2 r/ _- P% x! N" E/ p% VLB2. TransRadial versus transfemoral Arterial access for CErebral angiography [! g- P5 A. G' N$ z
Wei Ni, Huashan Hospital, Fudan University, Shanghai, China" u& X/ s, s# b+ M7 A- b
" ?3 y4 Z$ S1 l/ G( G; d' }5 {8 h
LB17. Intensive Blood Pressure Lowering After Thrombectomy in Ischemic Stroke Patients-A Randomized Clinical Trial
/ u& T2 v/ Q- w4 T W( W5 x& V, VXuening Zhang, West China Hospital, Sichuan University, Chendu, China
8 D8 v1 v- Q1 C
3 O9 |2 [2 w9 F# f/ z# ZLB38. Intra-arterial Tenecteplase thrombolysis for acute LVO after successful mechanical thrombectomy recanalization (ANGEL-TNK) — A Multicenter, Prospective, Randomized, Open-label, Blinded End-point Trial
: i0 q& M1 C) B' w$ m" @" v" c C/ gMiao Zhongrong, Beijing Tiantan Hospital, Beijing, China% J5 M0 b+ D8 p5 d
7 B) K% v+ N) r- j( U
LB39. The Optimal Dosage of ADjunctive Intra-Arterial Tenecteplase following Successful Endovascular Thrombectomy in Patients with Large Vessel Occlusion Acute Ischemic Stroke (DATE) Trail
6 K: z. H3 u; G6 g* N8 G1 kXianhua Hou, The First Affiliated Hospital, Army Medical University, Chongqing, China
2 O* T' T1 f$ P- Z2 p
# i {1 @) g R5 I# R; m7 ZLB41. Treatment with intravenous alteplase in ischemic stroke patients with onset time between 4.5 and 24 hours! w8 s5 Z& v* C) c% W3 m. j
Min Lou, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China
3 X) _: m5 s2 A9 }; S8 V8 l: G( L/ s* D
LB42. Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy (PEARL): A Multicenter Randomized Trial
( X- C! m! {- O# PYamei Tang, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
8 F9 |- y* L h! l7 V; ^. [! a0 M9 b! z4 W
LB44. Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients with Type 2 Diabetes Mellitus (LAMP): A Randomized Clinical Trial& S; D+ N, [8 q- F9 z, W: ]
Huili Zhu, The First Affiliated Hospital of Jinan University, Guangzhou, China
2 i- g8 w# c) f6 U( \! m3 ]( _
" {9 H7 J; D' b4 j, W0 S4 Z TLB45. BXOS110 for Acute Ischemic Stroke Treatment (BEST): A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial2 u- P' c2 I" P$ B
Yarong Ding, Beijing Tiantan Hospital, Beijing, China/ @* S+ Q6 g/ @6 U9 Y# S1 W
; w j& [' l: l& M0 J. o
祝贺以上单位!' W: c" R+ g1 n; \- z2 N# e
|
|